Dr. Seth O. Fagbemi
Claim this profileMarshfield Medical Center-EC Cancer Center
Area of expertise
Prostate Cancer
Seth O. Fagbemi has run 8 trials for Prostate Cancer. Some of their research focus areas include:
Urothelial Carcinoma
Seth O. Fagbemi has run 4 trials for Urothelial Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Marshfield Medical Center-EC Cancer Center
Marshfield Medical Center-Marshfield
Clinical Trials Seth O. Fagbemi is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
More about Seth O. Fagbemi
Clinical Trial Related
2 years of experience running clinical trials · Led 38 trials as a Principal Investigator · 13 Active Clinical Trials
Treatments Seth O. Fagbemi has experience with
- Nivolumab
- Fluorouracil
- Prednisone
- Docetaxel
- Ipilimumab
- Gemcitabine Hydrochloride
Breakdown of trials Seth O. Fagbemi has run
Prostate Cancer
Urothelial Carcinoma
Bladder Cancer
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Seth O. Fagbemi specialize in?
Seth O. Fagbemi focuses on Prostate Cancer and Urothelial Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Seth O. Fagbemi currently recruiting for clinical trials?
Yes, Seth O. Fagbemi is currently recruiting for 13 clinical trials in Eau Claire Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Seth O. Fagbemi has studied deeply?
Yes, Seth O. Fagbemi has studied treatments such as Nivolumab, Fluorouracil, Prednisone.
What is the best way to schedule an appointment with Seth O. Fagbemi?
Apply for one of the trials that Seth O. Fagbemi is conducting.
What is the office address of Seth O. Fagbemi?
The office of Seth O. Fagbemi is located at: Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin 54701 United States. This is the address for their practice at the Marshfield Medical Center-EC Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.